Igene Biotechnology, Inc. (IGNE)
USD 0.0
(-90.0%)
USD 0.0
(-90.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2009 | -851.28 Thousand USD | 63.09% |
| 2008 | -2.08 Million USD | -4223.22% |
| 2007 | 324.57 Thousand USD | 118.31% |
| 2006 | -307.51 Thousand USD | 0.0% |
| 2003 | -540.95 Thousand USD | -2.07% |
| 2002 | -1.67 Million USD | -646.47% |
| 2001 | -1.5 Million USD | 84.12% |
| 2000 | -1.4 Million USD | 22.7% |
| 1999 | -1.23 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2010 Q1 | -109.91 Thousand USD | 45.35% |
| 2010 Q2 | -102.74 Thousand USD | 6.53% |
| 2010 Q3 | -66.26 Thousand USD | 35.51% |
| 2009 Q2 | -229.18 Thousand USD | 77.83% |
| 2009 FY | - USD | 63.09% |
| 2009 Q4 | -201.14 Thousand USD | -132.83% |
| 2009 Q1 | -1.03 Million USD | 23.2% |
| 2009 Q3 | 612.67 Thousand USD | 367.33% |
| 2008 Q1 | -320.74 Thousand USD | -608.25% |
| 2008 Q4 | -1.34 Million USD | -460.15% |
| 2008 Q3 | -240.28 Thousand USD | 39.83% |
| 2008 Q2 | -399.31 Thousand USD | -24.5% |
| 2008 FY | - USD | -4223.22% |
| 2007 Q1 | -13.58 Thousand USD | 82.66% |
| 2007 Q2 | -38.79 Thousand USD | -185.58% |
| 2007 FY | - USD | 118.31% |
| 2007 Q4 | 63.1 Thousand USD | 34.88% |
| 2007 Q3 | 46.78 Thousand USD | 220.6% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | -78.35 Thousand USD | -80.94% |
| 2006 Q3 | -43.3 Thousand USD | 61.38% |
| 2006 Q2 | -112.12 Thousand USD | -56.54% |
| 2006 Q1 | -71.62 Thousand USD | 0.0% |
| 2005 Q3 | -11.45 Thousand USD | 0.0% |
| 2004 Q1 | -401.49 Thousand USD | -18.41% |
| 2004 Q2 | -562.9 Thousand USD | -40.2% |
| 2004 Q3 | -421.9 Thousand USD | 25.05% |
| 2003 Q2 | 20.65 Thousand USD | 105.85% |
| 2003 FY | - USD | -2.07% |
| 2003 Q1 | -353.35 Thousand USD | -548.14% |
| 2003 Q3 | -171.75 Thousand USD | -2150.12% |
| 2003 Q4 | -36.05 Thousand USD | 19.93% |
| 2002 Q2 | -323.33 Thousand USD | 0.27% |
| 2002 FY | - USD | -646.47% |
| 2002 Q1 | -439.11 Thousand USD | -143.78% |
| 2002 Q4 | -54.51 Thousand USD | 93.85% |
| 2002 Q3 | -690.92 Thousand USD | -94.63% |
| 2001 Q3 | -593.31 Thousand USD | -65.61% |
| 2001 Q2 | -355.25 Thousand USD | -15.71% |
| 2001 FY | - USD | 84.12% |
| 2001 Q1 | -306.61 Thousand USD | -8.38% |
| 2001 Q4 | -249.4 Thousand USD | 275.85% |
| 2000 Q3 | -448.9 Thousand USD | -17.65% |
| 2000 Q4 | -325.66 Thousand USD | 36.65% |
| 2000 Q2 | -381.12 Thousand USD | -52.26% |
| 2000 Q1 | -251.72 Thousand USD | 0.0% |
| 2000 FY | - USD | 22.7% |
| 1999 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Allied Energy Corporation | -279.93 Thousand USD | -204.1% |
| Earth Alive Clean Technologies Inc. | -4.04 Million USD | 78.968% |
| Lotus Bio-Technology Development Corp. | - USD | Infinity% |
| MagIndustries Corp. | -27.23 Million USD | 96.874% |
| Itafos Inc. | 53.75 Million USD | 101.584% |
| Potash America, Inc. | -317.38 Thousand USD | -168.223% |
| Yara International ASA | 1.45 Billion USD | 100.058% |
| Yara International ASA | 1.51 Billion USD | 100.056% |